| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 9.2e-05 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 6e-05 | 1 |